Should the Pharmaceutical Benefits Advisory Committee extend the range of free nicotine replacement therapies available for Aboriginal and Torres Strait Islander people?

Robertson, Jan A. , MacLaren, David J., and Clough, Alan R. (2009) Should the Pharmaceutical Benefits Advisory Committee extend the range of free nicotine replacement therapies available for Aboriginal and Torres Strait Islander people? Medical Journal of Australia, 191 (5). p. 293.

[img] PDF (Published Version)
Restricted to Repository staff only

View at Publisher Website: http://www.mja.com.au.elibrary/public/is...

Abstract

To the Editor: In March 2008, nicotine patches (15 mg per 16 hours) were authority-listed for Aboriginal and Torres Strait Islander people by the Pharmaceutical Benefits Advisory Committee (PBAC) as part of efforts to improve access to medications.1,2 Although timely and welcome, the decision to list only 15 mg patches should be revisited, as it is not consistent with current smoking cessation clinical guidelines.3-5 Neither is it consistent with evidence from a 2008 tobacco survey that we conducted in remote Aboriginal communities in Arnhem Land, Northern Territory.

Item ID: 9566
Item Type: Article (Commentary)
ISSN: 1326-5377
Date Deposited: 03 Jun 2010 03:03
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111701 Aboriginal and Torres Strait Islander Health @ 50%
11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111706 Epidemiology @ 50%
SEO Codes: 92 HEALTH > 9203 Indigenous Health > 920399 Indigenous Health not elsewhere classified @ 50%
92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920410 Mental Health @ 25%
92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920414 Substance Abuse @ 25%
Citation Count from Web of Science Web of Science 3
Downloads: Total: 3
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page